COVID-19: NAFDAC approves Pfizer Biotech Vaccine for emergen

COVID-19: NAFDAC approves Pfizer Biotech Vaccine for emergency use authorisation


COVID-19: NAFDAC approves Pfizer Biotech Vaccine for emergency use authorisation
On
Kindly Share This Story:
The National Agency for Food and Drug Administration and Control (NAFDAC) says it has approved the Pfizer Biotech Vaccine for emergency use authorisation for COVID-19 in Nigeria.
Its Director-General, Prof. Mojisola Adeyeye, made this known on Friday in a live/zoom media briefing in Lagos.
Adeyeye said: “We have approved Pfizer Biotech Vaccine for possible use in the country.
“Our COVID-19 vaccine team must carefully review it to make sure that the science behind it is well understood, and also in accordance with our own regulation.”

Related Keywords

Lagos , Nigeria , Mojisola Adeyeye , Pfizer , International Coalition Of Medicine Regulatory Authorities , Vaccine Committee , National Agency For Food , Drug Administration , World Health Organisation , Kindly Share This Story , National Agency , Pfizer Biotech Vaccine , International Coalition , Medicine Regulatory Authorities , Oxford Astrazeneca Vaccine , Share This Story , லாகோஸ் , நைஜீரியா , ஃபைசர் , சர்வதேச கூட்டணி ஆஃப் மருந்து ஒழுங்குமுறை அதிகாரிகள் , தடுப்பூசி குழு , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , கைஂட்லீ பகிர் இது கதை , சர்வதேச கூட்டணி , மருந்து ஒழுங்குமுறை அதிகாரிகள் , பகிர் இது கதை ,

© 2025 Vimarsana